[go: up one dir, main page]

WO2003104180A1 - Process for the preparation of 4-(4-fluorobenzoyl) butyric acid - Google Patents

Process for the preparation of 4-(4-fluorobenzoyl) butyric acid Download PDF

Info

Publication number
WO2003104180A1
WO2003104180A1 PCT/IN2003/000159 IN0300159W WO03104180A1 WO 2003104180 A1 WO2003104180 A1 WO 2003104180A1 IN 0300159 W IN0300159 W IN 0300159W WO 03104180 A1 WO03104180 A1 WO 03104180A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
compound
fluorobenzene
preparation
improved process
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2003/000159
Other languages
French (fr)
Inventor
Muddasani Pulla Reddy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Natco Pharma Ltd
Original Assignee
Natco Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natco Pharma Ltd filed Critical Natco Pharma Ltd
Priority to AU2003237593A priority Critical patent/AU2003237593A1/en
Priority to US10/516,770 priority patent/US20050250961A1/en
Publication of WO2003104180A1 publication Critical patent/WO2003104180A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/083Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid anhydrides

Definitions

  • the present invention relates to an improved process for the preparation of 4-(4- fluorobenzoyl)butyric acid.
  • the 4-(4-fluorobenzoyl)butyric acid has the formula-I given below.
  • the 4-(4-fluorobenzoyl)butyric acid has the formula-I is a key raw material for the synthesis of anti-hyperlipoproteinemetic drug ezetimibe (US 5767115, Schering).
  • the main criticality in making the compound of formula-I lies in controlling the desfluoro analogue impurity (4-benzoylbutyric acid) at an acceptable level ( ⁇ 0.05% w/w by HPLC).
  • the main objective of the present invention is, therefore, to provide an improved process for the preparation of compound of formula-I as defined above overcoming all the disadvantages present in the hitherto known processes.
  • Another objective of the present invention is to provide an improved process for the preparation of compound of formula-I as defined above which is simple and economical.
  • Another objective of the present invention is to provide an improved process for the preparation of compound of formula-I as defined above which does not have any mixing problem when the process is used on any scale of operation
  • Another objective of the present invention is to provide an improved process for the preparation of compound of formula-I as defined above which does not have reaction quenching problem when the process is used on any scale of operation
  • Still another objective of the present invention is to provide an improved process for the preparation of compound of formula-I as defined above which does not require high quality fluorobenzene
  • Another objective of the present invention is to provide an improved process for the preparation of compound of formula-I as defined above which does not require fluorobenzene as solvent medium to carry out the Friedel-Crafts reaction SUMARY OF INVENTION
  • the present invention provides an improved process for the preparation of compound (4-4(fluorobenzoyl)butyric acid) of the formula-I
  • I which comprises: (a) Preparing a solution of normal quality fluorobenzene, glutaric anhydride and halogenated solvent, the amount of fluorobenzene used being in a molar ratio of 0.5 to 0.7 molar equivalent with regard to the amount of glutaric anhydride used. (b) Preparing a mixture of aluminum chloride, normal quality fluorobenzene and halogenated solvent, the amount of fluorobenzene used being in a molar ratio of 0.5 to 0.6 molar equivalent with regard to the amount of glutaric anhydride used and the amount of halogenated solvent used being at least 4-6 times (w/v) with regard to the amount of glutaric anhydride used.
  • step (c) Adding the solution obtained in step (a) to the mixture obtained in step (b) at a • temperature in the range of 10 to 25°C.
  • step (g) Filtering and washing the residue with the same halogenated solved used in step (b) above to obtain the compound of the formula-I.
  • the normal quality of fluorobenzene used in step (a) refers to the impurity level of benzene.
  • the benzene content in fluorobenzene may be between 300-700ppm.
  • the halogenated solvent used in step (b) may be selected form methylene chloride, ethylene dichloride, 1,1,2,2-tetrachloroethane.
  • the base used in step (h) may be selected from sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, sodium hydroxide, potassium hydroxide, and ammonia.
  • the acid used in step (h) may be selected from hydrochloric acid, hydrobromic acid, sulfuric acid, acetic acid, and propionic acid.
  • the solvent used for recrystallization in step (j) may be selected from acetone, methyl ethyl ketone, methyl isobutyl ketone, toluene, acetonitrile, methanol, ethanol, ethyl acetate, hexane or a mixture of these solvents.
  • Tnto a 3L three-necked RB flnsk were charged 500ml of methylene chloride, 250 ⁇ r of aluminum chloride and 45gr of fluorobenzene (benzene content 700ppm) under nitrogen atmosphere.
  • the reaction mixture was cooled to 10°C and a solution of lOOgr of glutaric anhydride, 45gr of fluorobenzene (benzene content 700ppm) and 500ml of methylene chloride was added slowly over a period of 3hrs between 10-15°C.
  • the reaction mixture was maintained for another one hour at the same temperature.
  • the reaction mixture was slowly poured onto a mixture of crushed ice (700gr) and cone. HC1 (300ml) below 10°C.
  • the reaction mass temperature was allowed to reach 25°C and methylene chloride distilled off from the reaction mixture below 50°C. After cooling the reaction mixture to 20°C, solids were filtered off and washed with 500ml of water.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention provides an improved process for the preparation of 4-(4-Fluorobenzoyl)butyric acid of formula (I), which is prepared on a commercial scale using normal quality fluorobenzene (benzene content 300-700ppm) with the desfluoro analogue impurity at an acceptable level (less than 0.1 % by HPLC). The 4-(4-fluorobenzoyl)butyric acid has the formula (I) is a key raw material for the synthesis of anti-hyperlipoproteinemetic drug ezetimibe.

Description

PROCESS FOR THE PREPARATION OF 4-(4-FLUOROBENZOYL) BUTYRIC ACID
INTRODUCTION
The present invention relates to an improved process for the preparation of 4-(4- fluorobenzoyl)butyric acid. The 4-(4-fluorobenzoyl)butyric acid has the formula-I given below.
Figure imgf000002_0001
The 4-(4-fluorobenzoyl)butyric acid has the formula-I is a key raw material for the synthesis of anti-hyperlipoproteinemetic drug ezetimibe (US 5767115, Schering). The main criticality in making the compound of formula-I lies in controlling the desfluoro analogue impurity (4-benzoylbutyric acid) at an acceptable level (< 0.05% w/w by HPLC).
BACKGROUND OF THE INVENTION
In the literature only two procedures are known for the preparation of compound of formula-I. In the first procedure reported by Compernolle (Tetrahedron, 49, 3193, 1993) fluorobenzene is reacted with glutaric anhydride under Friedel-Crafts conditions using aluminium chloride at 0°C to get the compound of formula-I in 78% yield. The reaction is done in methylene chloride medium. In this procedure reaction was done on a 15gr glutaric anhydride scale. The quality of final product with respect to impurities is not addressed in this reference. The main drawbacks in this procedure are: 1. Temperature of the reaction (0°C) is not suitable for scale up operations. At 0°C aluminum chloride-glutaric anhydrde complex is not soluble in the medium and a thick mass (difficult to stir by mechanical stirrer) will form. Because of improper mixing quality and yield of the product is low.
2. Quenching of Friedel-Crafts reaction by adding water or acid to the reaction mass is difficult on a larger scale.
3. Quality of fluorobenzene used in the process is not mentioned. This is very critical to get an acceptable quality of compound of formula-I with respect to desfluoro analogue impurity.
In the second route (US patent, 6,207,822) for the synthesis of compound of formula-I, fluorobenzene is used as a solvent-cum-reagent in the Friedel-Crafts acylation with glutaric anhydride. The yield of compound of the formula-I reported in this procedure is 79%). The reaction is done at 5-12°C. The main disadvantages in this process are:
1. It requires high quality (benzene content in fluorobenzene should be less than lOOppm) fluorobenzene to get acceptable quality compound of formula-I.
2. Availability of high quality fluorobenzene is limited for employing the process on a commercial scale.
Price of high quality fluorobenzene is almost 4 times higher than the normal quality (benzene content is 300-700ppm) fluorobenzene. Normal quality fluorobenzene is abundantly available in the market. Keeping in view of the above mentioned difficulties in implementing the above routes for making compound of formula-I on a commercial scale, we directed our research work to develop a simple, convenient, and economical process for the preparation of compound of formula-I which can also be utilized on a commercial scale
The main objective of the present invention is, therefore, to provide an improved process for the preparation of compound of formula-I as defined above overcoming all the disadvantages present in the hitherto known processes.
Another objective of the present invention is to provide an improved process for the preparation of compound of formula-I as defined above which is simple and economical.
Another objective of the present invention is to provide an improved process for the preparation of compound of formula-I as defined above which does not have any mixing problem when the process is used on any scale of operation
Another objective of the present invention is to provide an improved process for the preparation of compound of formula-I as defined above which does not have reaction quenching problem when the process is used on any scale of operation
Still another objective of the present invention is to provide an improved process for the preparation of compound of formula-I as defined above which does not require high quality fluorobenzene
Another objective of the present invention is to provide an improved process for the preparation of compound of formula-I as defined above which does not require fluorobenzene as solvent medium to carry out the Friedel-Crafts reaction SUMARY OF INVENTION
In our preliminary studies in the course of the R&D towards development of an improved process for the preparation of compound of formula-I as defined above we found that benzene is more reactive (about 5 times) than fluorobenzene in the above mentioned Friedel-Crafts acylation. This indicates that benzene present in fluorobenzene will react faster than fluorobenzene. Considering this observation we found that
(i) by adjusting the ratio of fluorobenzene with regard to the glutaric anhydride used, (ii) dividing the amount of fluorobenzene used into two parts - one along with glutaric anhydride and another part with the halogenated solvent and
(iii) fixing the quantity of the halogenated solvent used, a process cab be developed for the preparation of compound of the formula-I as defined above which overcomes the drawbacks of the hitherto known processes described above, Further the process developed can also be useful for any commercial scale production of the said compound of the formula-I. The reaction can be conducted at a convenient temperature range of 10 to 25°C.
Accordingly, the present invention provides an improved process for the preparation of compound (4-4(fluorobenzoyl)butyric acid) of the formula-I
Figure imgf000005_0001
I which comprises: (a) Preparing a solution of normal quality fluorobenzene, glutaric anhydride and halogenated solvent, the amount of fluorobenzene used being in a molar ratio of 0.5 to 0.7 molar equivalent with regard to the amount of glutaric anhydride used. (b) Preparing a mixture of aluminum chloride, normal quality fluorobenzene and halogenated solvent, the amount of fluorobenzene used being in a molar ratio of 0.5 to 0.6 molar equivalent with regard to the amount of glutaric anhydride used and the amount of halogenated solvent used being at least 4-6 times (w/v) with regard to the amount of glutaric anhydride used.
(c) Adding the solution obtained in step (a) to the mixture obtained in step (b) at a • temperature in the range of 10 to 25°C.
(d) Maintaining the resulting reaction mixture at a temperature in the range of 10 to 25°C for a period in the range of 2 to 4hrs. (e) Pouring the reaction mixture into cold dilute hydrochloric acid.
(f) Distilling the halogenated solvent at atmospheric pressure for its recovery.
(g) Filtering and washing the residue with the same halogenated solved used in step (b) above to obtain the compound of the formula-I.
(h) Purifying the compound of the formula-I by dissolving it in aqueous base and precipitating the product by acidification after giving a carbon treatment to the basic solution, (i) Isolating the precipitated compound of formula-I by filtration and if desired (j) Recrystallizing the purified acid from a single or mixture of solvents.
The normal quality of fluorobenzene used in step (a) refers to the impurity level of benzene. The benzene content in fluorobenzene may be between 300-700ppm. The halogenated solvent used in step (b) may be selected form methylene chloride, ethylene dichloride, 1,1,2,2-tetrachloroethane. The base used in step (h) may be selected from sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, sodium hydroxide, potassium hydroxide, and ammonia. The acid used in step (h) may be selected from hydrochloric acid, hydrobromic acid, sulfuric acid, acetic acid, and propionic acid. The solvent used for recrystallization in step (j) may be selected from acetone, methyl ethyl ketone, methyl isobutyl ketone, toluene, acetonitrile, methanol, ethanol, ethyl acetate, hexane or a mixture of these solvents. The details of the invention are described in Examples given below which are provided to illustrate the invention only and therefore should not be construed to limit the scope of the present invention.
Example 1
Preparation of 4-(4-fluorobenzoy)lbutyric acid of formula-I using fluorobenzene (benzene content 300ppm) with methylene chloride as solvent:
Into a 3L three-necked RB flask were charged 500ml of methylene chloride, 250gr of aluminum chloride and 45gr of fluorobenzene (benzene content 300ppm) under nitrogen atmosphere." The reaction mixture was cooled to 10°C and a solution of lOOgr of glutaric anhydride, 45gr of fluorobenzene (benzene content 300ppm) and 500ml of methylene chloride was added slowly over a period of 3hrs between 10-15°C. The reaction mixture was maintained for another one hour at the same temperature. The reaction mixture was slowly poured onto a mixture of crushed ice (700gr) and cone. HC1 (300ml) below 10°C. The reaction mass temperature was allowed to reach 25°C and methylene chloride distilled off from the reaction mixture below 50°C. After cooling the reaction mixture to 20°C, solids were filtered off and washed with 500ml of water.
The wet cake thus obtained was suspended in 250-300ml of methylene chloride and filtered. The solid compound was dissolved in 600ml of 4% sodium hydroxide, treated with lOgr of activated charcoal and filtered. The filtrate was acidified with cone. HC1 and the precipitated acid was filtered. After washing the wet cake with 500ml of water, it was dissolved in 500ml of acetone. The acetone solution was slowly cooled to 15-20°C and the solid filtered, washed with chilled acetone (50ml) and dried at 50-70°C to get 122gr of white crystalline solid, m.p. 143°C. Purity by HPLC is 99.65%. Desfluoro impurity is less than 0.05%. Example 2
Preparation of 4-(4-fluorobenzoy)lbutyric acid of formula-I using fluorobenzene (benzene content 500ppm) with methylene chloride as solvent:
Into a 3L three-necked RB flask were charged 500ml of methylene chloride, 250gr of aluminum chloride and 45gr of fluorobenzene (benzene content 500ppm) under nitrogen atmosphere. The reaction mixture was cooled to 10°C and a solution of lOOgr of glutaric anhydride, 45gr of fluorobenzene (benzene content 500ppm) and 500ml of methylene chloride was added slowly over a period of 3hrs between 10-15°C. The reaction mixture was maintained for another one hour at the same temperature. The reaction mixture was slowly poured onto a mixture of crushed ice (700gr) and cone. HC1 (300ml) below 10°C. The reaction mass temperature was allowed to reach 25°C and methylene chloride distilled off from the reaction mixture below 50°C. After cooling the reaction mixture to 20°C, solids were filtered off and washed with 500ml of water.
The wet cake thus obtained was suspended in 250-300ml of methylene chloride and filtered. The solid compound was dissolved in 600ml of 4%> sodium hydroxide, treated with lOgr of activated charcoal and filtered. The filtrate pH was adjusted to 1.0-2.0 with cone. HC1 and the precipitated acid of formula-I was filtered. After washing the wet cake with 500ml of water, it was dissolved in 500ml of acetone. The acetone solution was slowly cooled to 15-20°C, maintained for 2h, and the solid filtered, washed with chilled acetone (50ml) and dried at 50-70°C to get 120gr of white crystalline solid of formula-I, m.p. 143-143.5°C. Purity by HPLC is 99.7%. Desfluoro impurity is less than 0.05%. Example 3
Preparation of 4-(4-fluorobenzoy)lbutyric acid of formula-I using fluorobenzene (benzene content 700ppm) with methylene chloride as solvent:
Tnto a 3L three-necked RB flnsk were charged 500ml of methylene chloride, 250τr of aluminum chloride and 45gr of fluorobenzene (benzene content 700ppm) under nitrogen atmosphere. The reaction mixture was cooled to 10°C and a solution of lOOgr of glutaric anhydride, 45gr of fluorobenzene (benzene content 700ppm) and 500ml of methylene chloride was added slowly over a period of 3hrs between 10-15°C. The reaction mixture was maintained for another one hour at the same temperature. The reaction mixture was slowly poured onto a mixture of crushed ice (700gr) and cone. HC1 (300ml) below 10°C. The reaction mass temperature was allowed to reach 25°C and methylene chloride distilled off from the reaction mixture below 50°C. After cooling the reaction mixture to 20°C, solids were filtered off and washed with 500ml of water.
The wet cake thus obtained was suspended in 250-300ml of methylene chloride and filtered. The solid compound was dissolved in 600ml of 4% sodium hydroxide, treated with lOgr of activated charcoal and filtered. The filtrate pH was adjusted to 1.0-2.0 with cone. HC1 and the precipitated acid of formula-I was filtered. After washing the wet cake with 500ml of water, it was dissolved in 500ml of acetone. The acetone solution was slowly cooled to 15-20°C, maintained for 2h, and the solid filtered, washed with chilled acetone (50ml) and dried at 50-70°C to get 123gr of white crystalline solid of formula-I, m.p. 143°C. Purity by HPLC is 99.6%. Desfluoro impurity is less than 0.05%. Example 4
Preparation of 4-(4-fluorobenzoy)lbutyric acid of formula-I using fluorobenzene (benzene content 500ppm) with ethylene dichloride as solvent:
Into a 3L three-necked RB flask was charged ethylene dichloride (500ml), aluminum chloride (250gr) and fluorobenzene (45gr) under nitrogen atmosphere. The reaction mixture was cooled to 10°C and a solution of glutaric anhydride (lOOgr), fluorobenzene (45gr) and ethylene dichloride (500ml) was added slowly over a period of 3hrs between 10-15°C. After maintaining for one hour at 15-18°C the reaction mixture was slowly poured onto a mixture of crushed ice (700gr) and cone. HC1 (300ml) below 10°C. The reaction mass temperature was raised to reach 25 °C and distilled off ethylene dichloride from the reaction mixture below 100°C. After cooling the reaction mixture to 20°C, crude solid was filtered off and washed with 500ml of water.
The wet cake thus obtained was suspended in 300ml of ethylene dichloride and filtered. The solid compound was dissolved in 600ml of 4% sodium hydroxide, treated with 15gr of activated charcoal and filtered. The filtrate was acidified to pH 1.5-2.0 with cone. HC1 and the precipitated acid was filtered. After washing the wet cake with 500ml of water, it was dried at 60-70°C to get 130gr of white solid, m.p. 140-142°C. This solid was dissolved in 500ml of acetone. The acetone solution was slowly cooled to 15-20°C and the solid filtered, washed with chilled acetone (50ml) and dried at 50-70°C to get 120gr of white crystalline solid, m.p. 143°C. Purity by HPLC is 99.65%. Desfluoro impurity is less than 0.05%. Advantages of the present invention:
1. (a) By adjusting the ratio of fluorobenzene with regard to the glutaric anhydride used (b) dividing the amount of fluorobenzene used into two parts - one along with glutaric anhydride and another part with the halogenated- solvent and (c) conducting the
Friedel-Crafts acylation at 10-20°C, the process can be made applicable to any scale of operation.
2. By using halogenated solvent in the reaction, quality of required fluorobenzene could be relaxed to normal quality to make the process economical.
3. High quality compound of formula-I could be produced using normal quality fluorobenzene.

Claims

We Claim:
1. An improved process for the preparation of compound of formula-
Figure imgf000012_0001
which comprises:
(a) Preparing a solution of normal quality fluorobenzene, glutaric anhydride and halogenated solvent, the amount of fluorobenzene used being in a molar ratio of 0.5 to 0.7 molar equivalent with regard to the amount of glutaric anhydride used.
(b) Preparing a mixture of aluminum chloride, normal quality fluorobenzene and halogenated solvent, the amount of fluorobenzene used being in a molar ratio of 0.5 to 0.6 molar equivalent with regard to the amount of glutaric anhydride used and the amount of halogenated solvent used being at least 4-6 times (w/v) with regard to the amount of glutaric anhydride used.
(c) Adding the solution obtained in step (a) to the mixture obtained in step (b) at a temperature in the range of 10 to 25°C.
(d) Maintaining the reaction mixture at the temperature in the range of 10 to 25°C for a period in the range of 2 to 4hrs. (e) Pouring the reaction mixture into cold dilute hydrochloric acid.
(f) Distilling the halogenated solvent at atmospheric pressure for its recovery.
(g) Filtering and washing the residue with the same halogenated solved used in step (b) above to obtain the compound of the formula-I.
(h) Purifying the compound of the formula-I by dissolving it in aqueous base and precipitating the product by acidification after giving a carbon treatment to the basic solution. (i) Isolating the precipitated compound of formula-I by filtration and if desired (j) Recry stall izing the purified acid from a single or mixture of solvents.
2. An improved process for the preparation of compound of formula-I as claimed in claim l(i) wherein the normal quality fluorobenzene used in the process has a benzene content of 300-700ppm, preferably between 300-500ppm.
3. An improved process for the preparation of compound of formula-I as claimed in claims 1 & 2 wherein the halogenated solvent used in the reaction is methylene chloride, ethylene dichloride, 1,1,2,2-tetrachloroethylene, preferably methylene chloride or ethylene dichloride.
4. An improved process for the preparation of compound of formula-I as claimed in claims 1 to 3 wherein the quantity of solvent used is 6 to 10 times (w/v) on glutaric anhydride, preferably 8 to 10 times.
5., An improved process for the preparation of compound of formula-I as claimed in claims 1 to 4 wherein the reaction, temperature is between 10-25°C, preferably between 12-18°C.
6. An improved process for the preparation of compound of formula-I as claimed in claims 1 to 5 wherein the base used to dissolve the crude acid is ammonia, sodium carbonate, sodium bicarbonate, sodium hydroxide, potassium carbonate, potassium bicarbonate, potassium hydroxide, ammonia, preferably sodium hydroxide or - ammonia.
7. An improved process for the preparation of compound of formula-I as claimed in claims 1 to 6 wherein the acid used to neutralize the base is hydrochloric acid,
PCT/IN2003/000159 2002-06-05 2003-04-16 Process for the preparation of 4-(4-fluorobenzoyl) butyric acid Ceased WO2003104180A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2003237593A AU2003237593A1 (en) 2002-06-05 2003-04-16 Process for the preparation of 4-(4-fluorobenzoyl) butyric acid
US10/516,770 US20050250961A1 (en) 2002-06-05 2003-04-16 Process for the preparation of 4-(4-fluorobenzoyl) butyric acid

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN427/MAS/2002 2002-06-05
IN427CH2002 2002-06-05

Publications (1)

Publication Number Publication Date
WO2003104180A1 true WO2003104180A1 (en) 2003-12-18

Family

ID=29727194

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2003/000159 Ceased WO2003104180A1 (en) 2002-06-05 2003-04-16 Process for the preparation of 4-(4-fluorobenzoyl) butyric acid

Country Status (2)

Country Link
AU (1) AU2003237593A1 (en)
WO (1) WO2003104180A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020131807A1 (en) * 2018-12-17 2020-06-25 Vertex Pharmaceuticals Incorporated Inhibitors of apol1 and methods of using same
JP2023530276A (en) * 2020-06-12 2023-07-14 バーテックス ファーマシューティカルズ インコーポレイテッド Solid forms of APOL1 inhibitors and uses thereof
US11801234B2 (en) 2020-03-06 2023-10-31 Vertex Pharmaceuticals Incorporated Methods of treating APOL-1 dependent focal segmental glomerulosclerosis
US11866446B2 (en) 2020-08-26 2024-01-09 Vertex Pharmaceuticals Incorporated Inhibitors of APOL1 and methods of using same
US12116343B2 (en) 2020-01-29 2024-10-15 Vertex Pharmaceuticals Incorporated Inhibitors of APOL1 and methods of using same
US12281102B2 (en) 2020-06-12 2025-04-22 Vertex Pharmaceuticals Incorporated Inhibitors of APOL1 and methods of using same
CN120136685A (en) * 2025-05-15 2025-06-13 奥瑞隆新材料(山东)有限公司 A low-cost and environmentally friendly process for producing 1,4-di(4-fluorobenzoyl)benzene

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000034240A1 (en) * 1998-12-07 2000-06-15 Schering Corporation Process for the synthesis of azetidinones
US6207822B1 (en) * 1998-12-07 2001-03-27 Schering Corporation Process for the synthesis of azetidinones
WO2001038305A2 (en) * 1999-11-25 2001-05-31 Fournier Industrie Et Sante Novel il-8 receptor antagonists

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000034240A1 (en) * 1998-12-07 2000-06-15 Schering Corporation Process for the synthesis of azetidinones
US6207822B1 (en) * 1998-12-07 2001-03-27 Schering Corporation Process for the synthesis of azetidinones
WO2001038305A2 (en) * 1999-11-25 2001-05-31 Fournier Industrie Et Sante Novel il-8 receptor antagonists

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BAENS, NICOLE P. ET AL: "Synthesis of 2,5-substituted piperidines: transposition of 1,4-substitution pattern for the analgesic drug R6582", TETRAHEDRON (1993), 49(15), 3193-202, XP002022790 *

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL283592B1 (en) * 2018-12-17 2025-04-01 Vertex Pharma Inhibitors of apol1 and methods of using same
JP7573528B2 (en) 2018-12-17 2024-10-25 バーテックス ファーマシューティカルズ インコーポレイテッド APOL1 INHIBITORS AND METHODS OF USE THEREOF
JP2022515369A (en) * 2018-12-17 2022-02-18 バーテックス ファーマシューティカルズ インコーポレイテッド Inhibitor of APOL1 and its usage
US11618746B2 (en) 2018-12-17 2023-04-04 Vertex Pharmaceuticals Incorporated Inhibitors of APOL1 and methods of using same
IL283592B2 (en) * 2018-12-17 2025-08-01 Vertex Pharma APOL1 inhibitors and methods of using them
WO2020131807A1 (en) * 2018-12-17 2020-06-25 Vertex Pharmaceuticals Incorporated Inhibitors of apol1 and methods of using same
CN113453760A (en) * 2018-12-17 2021-09-28 弗特克斯药品有限公司 APOL1 inhibitors and methods of use thereof
US12060346B2 (en) 2018-12-17 2024-08-13 Vertex Pharmaceuticals Incorporated Inhibitors of APOL1 and methods of using same
TWI848031B (en) * 2018-12-17 2024-07-11 美商維泰克斯製藥公司 Inhibitors of apol1 and methods of using same
CN113453760B (en) * 2018-12-17 2024-05-24 弗特克斯药品有限公司 APOL1 inhibitors and methods of use thereof
US12116343B2 (en) 2020-01-29 2024-10-15 Vertex Pharmaceuticals Incorporated Inhibitors of APOL1 and methods of using same
US11801234B2 (en) 2020-03-06 2023-10-31 Vertex Pharmaceuticals Incorporated Methods of treating APOL-1 dependent focal segmental glomerulosclerosis
US12281102B2 (en) 2020-06-12 2025-04-22 Vertex Pharmaceuticals Incorporated Inhibitors of APOL1 and methods of using same
JP2023530276A (en) * 2020-06-12 2023-07-14 バーテックス ファーマシューティカルズ インコーポレイテッド Solid forms of APOL1 inhibitors and uses thereof
US11866446B2 (en) 2020-08-26 2024-01-09 Vertex Pharmaceuticals Incorporated Inhibitors of APOL1 and methods of using same
CN120136685A (en) * 2025-05-15 2025-06-13 奥瑞隆新材料(山东)有限公司 A low-cost and environmentally friendly process for producing 1,4-di(4-fluorobenzoyl)benzene

Also Published As

Publication number Publication date
AU2003237593A8 (en) 2003-12-22
AU2003237593A1 (en) 2003-12-22

Similar Documents

Publication Publication Date Title
RS50044B (en) POLYMORPHIC FORMS OF TELMISARTAN, PROCEDURE FOR THEIR PREPARATION AND THEIR APPLICATION FOR THE PREPARATION OF THE MEDICINAL PRODUCT
WO2003104180A1 (en) Process for the preparation of 4-(4-fluorobenzoyl) butyric acid
CA2683098C (en) Process for making galantamine
KR860001547B1 (en) Process for the preparation of the d-2-(6-methoxy-2-naphthyl)-propionic acid
US4350813A (en) Process for producing 7-alkoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1-phthalazone and its intermediates
JP2006528172A (en) Improved process for the preparation of α-polymorph eletriptan hydrobromic acid
US20050250961A1 (en) Process for the preparation of 4-(4-fluorobenzoyl) butyric acid
CN101104583A (en) A New Process for the Preparation of Diacerein by Two-step Oxidation
US6350880B1 (en) Crystalline or crystallized acid addition salt of losartan and purification method of losartan
JPH10245352A (en) Purification of biscresol compounds
JP3291987B2 (en) Purification method of O, S-dimethyl-N-acetylphosphoramidothioate
JP3184345B2 (en) Method for producing 5-chlorooxindole
US4464532A (en) Intermediates of 7-alkoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1-phthalazone
HU204783B (en) Process for producing 2,4,5-tribromopyrrol-3-carbonitrile derivatives
JP4853691B2 (en) α, ω-Dihydroxy-δ, (ω-3) -alkanedione, ω-hydroxy- (ω-3) -keto fatty acid and salt thereof, and dicarboxylic acid and salt recovery method
JP3523661B2 (en) Method for purifying 2-alkyl-4-halogeno-5-formylimidazole
JP3084577B2 (en) Method for producing optically active atrolactic acid and intermediate for production
JP3010819B2 (en) Method for purifying 2,4-dichloro-3-ethyl-6-nitrophenol
JPH03275641A (en) Hydroxybiphenyl compound and its manufacturing method
JP2000198779A (en) Purification method of 3-alkyl flavanol derivative
JP2002173607A (en) Method for producing fluoran compound
JP3495417B2 (en) Method for producing 2-alkoxy-3,5-dihalogeno-6-nitrobenzoic acids
JPH093059A (en) Process for producing α-methyl-2-thiopheneacetic acid derivative
WO2004089924A1 (en) Process for the preparation of 5-bromophthalide
JP2000212136A (en) Recrystallization of 1,3-bis(aminophenoxybenzene)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 10516770

Country of ref document: US

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP